Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-016878
Filing Date
2020-06-17
Accepted
2020-06-17 16:50:54
Documents
2
Period of Report
2020-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6581
2 EX-24 DOCUMENT attachment1.htm EX-24 2691
  Complete submission text file 0000899243-20-016878.txt   10755
Mailing Address 4242 CAMPUS POINT COURT, SUITE 500 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 500 SAN DIEGO CA 92121 (858) 412-8400
Forte Biosciences, Inc. (Issuer) CIK: 0001419041 (see all company filings)

EIN.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FORTE BIOSCIENCES, INC. 1124 W. CARSON ST., MRL BLDG 3-320 TORRANCE CA 90502
Business Address
Eichenfield Lawrence (Reporting) CIK: 0001814892 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38052 | Film No.: 20970287